PHENYTOIN CUMULATION KINETICS

被引:26
作者
ALLEN, JP
LUDDEN, TM
BURROW, SR
CLEMENTI, WA
STAVCHANSKY, SA
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,DIV CLIN PHARMACOL,SAN ANTONIO,TX 78284
[2] UNIV TEXAS,COLL PHARM,INST DRUG DYNAM,AUSTIN,TX 78712
[3] PEORIA MED SCH,DEPT NEUROSCI,PEORIA,IL
关键词
D O I
10.1002/cpt1979264445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Four male subjects were given phenytoin orally in single or twice-daily doses. Subjects were on 2 or 3 different dosing rates from 260 to 600 mg phenytoin sodium daily. Predose blood samples were obtained almost daily. The resulting serum levels, measured by gas-liquid chromatography, ranged from 1 to 18 μg/ml. Serum phenytoin concentration-time data were fit to a 1-compartment open model with zero-order input and Michaelis-Menten elimination. The resulting computer-generated parameter estimates (Vmax, 5.28 to 8.41 mglkglday; Km, 0.83 to 4.18 mg/1; Vd, 0.74 to 0.97 1/kg) are in agreement with the ranges of values in the literature. The time course of phenytoin cumulation is compatible with the presence of a major elimination pathway exhibiting Michaelis-Menten kinetic behavior. © 1979.
引用
收藏
页码:445 / 448
页数:4
相关论文
共 23 条
[1]  
ARNOLD K, 1970, CLIN PHARMACOL THER, V11, P121
[2]  
ATKINSON AJ, 1973, CLIN PHARMACOL THER, V14, P521
[3]  
AYERS GJ, 1976, LANCET, V1, P809
[4]   STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].
BOXENBAU.HG ;
RIEGELMA.S ;
ELASHOFF, RM .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148
[5]   PHARMACOKINETIC ANALYSIS OF DRUG CONCENTRATION DATA OBTAINED DURING REPETITIVE DRUG ADMINISTRATION [J].
COLBURN, WA ;
SHEN, D ;
GIBALDI, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (06) :469-486
[6]   ELIMINATION OF PHENYTOIN IN MAN [J].
EADIE, MJ ;
TYRER, JH ;
BOCHNER, F ;
HOOPER, WD .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1976, 3 (03) :217-224
[7]  
GARRETTSON LK, 1975, CLIN PHARMACOL THER, V17, P481
[8]  
GERBER N, 1972, RES COMMUN CHEM PATH, V3, P455
[9]   ACUTE INTOXICATION WITH 5,5-DIPHENYLHYDANTOIN (DILANTIN) ASSOCIATED WITH IMPAIRMENT OF BIOTRANSFORMATION - PLASMA LEVELS AND URINARY METABOLITES - STUDIES IN HEALTHY VOLUNTEERS [J].
GERBER, N ;
LYNN, R ;
OATES, J .
ANNALS OF INTERNAL MEDICINE, 1972, 77 (05) :765-+
[10]  
GLAZKO AJ, 1969, CLIN PHARMACOL THER, V10, P498